Pharmacists may have noticed greater emergency contraception (EC) use among teens over the last decade, a new US Centers for Disease Control and Prevention (CDC) study suggests.
The FDA has expanded the indication for Amgen's carfilzomib (Kyprolis) in combination with lenalidomide (Revlimid) and dexamethasone to treat patients with relapsed multiple myeloma who have received at least 1 prior therapy.
With biosimilars set to enter the US health care market, pharmacists will soon have new factors to consider when selecting and dispensing products.
The Institute for Safe Medicine Practices (ISMP) recently outlined safe practices for certain error-prone medications.
Each of these OTC products will be sitting on your pharmacy’s shelves soon, if they aren’t already.